Neuroendocrine immunomodulation network dysfunction in SAMP8 mice and PrP-hAβPPswe/PS1δE9 mice: Potential mechanism underlying cognitive impairment

Oncotarget

Volumn 7, Issue 17, 2016, Pages 22988-23005

  Wang, Jian Hui ^a,b   Cheng, Xiao Rui ^a,b   Zhang, Xiao Rui ^a,b   Wang, Tong Xing ^a,b   Xu, Wenjian ^c   Li, Fei ^c   Liu, Feng ^a,b   Cheng, Jun Ping ^a,b   Bo, Xiao Chen ^c   Wang, Sheng Qi ^c   Zhou, Wen Xia ^a,b   Zhang, Yong Xiang ^a,b  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b State Key Laboratory of Toxicology and Medical Countermeasures   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Alzheimer's disease; Gerotarget; Learning and memory; Neuroendocrine immunemodulation; PrPhA PPswe PS1 E9(APP PS1) mice; Senescence accelerated mouse prone 8 strain (SAMP8)

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; EOTAXIN; FOLLITROPIN; GAMMA INTERFERON; GONADORELIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; LUTEINIZING HORMONE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ACTIVE AVOIDANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; CELLULAR IMMUNITY; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; INTRACELLULAR SIGNALING; LYMPHOCYTE ACTIVATION; MEMORY; MORRIS WATER MAZE TEST; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEUROENDOCRINE IMMUNOMODULATION NETWORK DYSFUNCTION; NEUROPATHOLOGY; NONHUMAN; OBJECT RECOGNITION MEMORY; PASSIVE AVOIDANCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PRP HA BETA PPSWE PS1 DELTA 9 MOUSE; SENESCENCE ACCELERATED MOUSE PRONE 8 MOUSE; SPATIAL LEARNING; SPATIAL MEMORY; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; CELL AGING; DISEASE MODEL; GENE REGULATORY NETWORK; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; MALE; METABOLISM; NEUROENDOCRINE SYSTEM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; CELLULAR SENESCENCE; COGNITIVE DYSFUNCTION; DISEASE MODELS, ANIMAL; GENE REGULATORY NETWORKS; HUMANS; IMMUNOMODULATION; MALE; MICE; MICE, TRANSGENIC; NEUROSECRETORY SYSTEMS; PRESENILIN-1;

EID: 84966588633     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8453     Document Type: Article

References (63)

1. Mangialasche F, Solomon A, Winblad B, Mecocci P and Kivipelto M. Alzheimer's disease: clinical trials and drug development. The Lancet Neurology. 2010; 9:702-716.
2. Smith AD. Why are drug trials in Alzheimer's disease failing? Lancet. 2010; 376:1466.
3. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V and Macleod MR. Can animal models of disease reliably inform human studies? PLoS medicine. 2010; 7:e1000245.
4. Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jaggi F, Wolburg H, Gengler S, Haass C, Ghetti B, Czech C, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO reports. 2006; 7:940-946.
5. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE and Diamond DM. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 2001; 891:42-53.
6. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG and Borchelt DR. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloidpeptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Human molecular genetics. 2004; 13:159-170.
7. Malm TM, Iivonen H, Goldsteins G, Keksa-Goldsteine V, Ahtoniemi T, Kanninen K, Salminen A, Auriola S, Van Groen T, Tanila H and Koistinaho J. Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden. The Journal of neuroscience. 2007; 27:3712-3721.
8. Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Thiele A and Heneka MT. Distinct Adrenergic System Changes And Neuroinflammation In Response To Induced Locus Ceruleus Degeneration In App/Ps1 Transgenic Mice. Neuroscience. 2011; 176:396-407.
9. Yan P, Bero AW, Cirrito JR, Xiao Q, Hu X, Wang Y, Gonzales E, Holtzman DM and Lee JM. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. The Journal of neuroscience. 2009; 29:10706-10714.
10. Leroy K, Ando K, Laporte V, Dedecker R, Suain V, Authelet M, Heraud C, Pierrot N, Yilmaz Z, Octave JN and Brion JP. Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice. The American journal of pathology. 2012; 181:1928-1940.
11. Mitew S, Kirkcaldie MT, Dickson TC and Vickers JC. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice. Neurobiol Aging. 2013; 34:2341-2351.
12. Kawamata T, Akiguchi I, Yagi H, Irino M, Sugiyama H, Akiyama H, Shimada A, Takemura M, Ueno M, Kitabayashi T, Ohnishi K, Seriu N, Higuchi K, et al. Neuropathological studies on strains of senescenceaccelerated mice (SAM) with age-related deficits in learning and memory. Experimental gerontology. 1997; 32:161-169.
13. Morley JE, Armbrecht HJ, Farr SA and Kumar VB. The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochimica et biophysica acta. 2012; 1822:650-656.
14. Kang L, Li S, Xing Z, Li J, Su Y, Fan P, Wang L and Cui H. Dihydrotestosterone treatment delays the conversion from mild cognitive impairment to Alzheimer's disease in SAMP8 mice. Hormones And Behavior. 2014; 65:505-515.
15. Novella S, Dantas AP, Segarra G, Novensa L, Bueno C, Heras M, Hermenegildo C and Medina P. Gathering of aging and estrogen withdrawal in vascular dysfunction of senescent accelerated mice. Experimental gerontology. 2010; 45:868-874.
16. Jiang T, Yu J-T, Zhu X-C, Tan M-S, Gu L-Z, Zhang Y-D and Tan L. Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice. Neurobiology of Aging. 2014; 35:1243-1251.
17. Tha KK, Okuma Y, Miyazaki H, Murayama T, Uehara T, Hatakeyama R, Hayashi Y and Nomura Y. Changes in expressions of proinflammatory cytokines IL-1 beta, TNFalpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Research. 2000; 885:25-31.
18. Masek K, Slansky J, Petrovicky P and Hadden JW. Neuroendocrine immune interactions in health and disease. Int Immunopharmacol. 2003; 3:1235-1246.
19. Cui X, He H, He F, Wang S, Li F and Bo X. Network fingerprint: a knowledge-based characterization of biomedical networks. Scientific reports. 2015; 5:13286.
20. Hatzinger M, Z'Brun A, Hemmeter U, Seifritz E, Baumann F, Holsboer-Trachsler E and Heuser IJ. Hypothalamicpituitary-adrenal system function in patients with Alzheimer's disease. Neurobiol Aging. 1995; 16:205-209.
21. Swanwick GR, Coen RF, Walsh JB, Coakley D and Lawlor BA. The predictive value of hypothalamic-pituitaryadrenal axis dysfunction in Alzheimer's disease. Biological psychiatry. 1996; 39:976-978.
22. Brookmeyer R, Gray S and Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American journal of public health. 1998; 88:1337-1342.
23. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A and Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997; 48:132-138.
24. McGonigal G, Thomas B, McQuade C, Starr JM, MacLennan WJ and Whalley LJ. Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88. Bmj. 1993; 306:680-683.
25. Flood JF, Farr SA, Kaiser FE, La Regina M and Morley JE. Age-related decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory. Physiology & behavior. 1995; 57:669-673.
26. Bernstein LR, Mackenzie ACL, Kraemer DC, Morley JE, Farr S, Chaffin CL and Merchenthaler I. Shortened Estrous Cycle Length, Increased FSH Levels, FSH Variance, Oocyte Spindle Aberrations, and Early Declining Fertility in Aging Senescence-Accelerated Mouse Prone-8 (SAMP8) Mice: Concomitant Characteristics of Human Midlife Female Reproductive Aging. Endocrinology. 2014; 155:2287-2300.
27. Ma Y, Zhou W-X, Cheng J-P and Zhang Y-X. Age-related changes in the oestrous cycle and reproductive hormones in senescence-accelerated mouse (vol 17, pg 507, 2005). Reproduction Fertility And Development. 2009; 21:624-U133.
28. Gao HB, Tong MH, Hu YQ, Guo QS, Ge R and Hardy MP. Glucocorticoid induces apoptosis in rat leydig cells. Endocrinology. 2002; 143:130-138.
29. Guzeloglu A, Ambrose JD, Kassa T, Diaz T, Thatcher MJ and Thatcher WW. Long-term follicular dynamics and biochemical characteristics of dominant follicles in dairycows subjected to acute heat stress. Animal reproduction science. 2001; 66:15-34.
30. Warren MP and Perlroth NE. The effects of intense exercise on the female reproductive system. The Journal of endocrinology. 2001; 170:3-11.
31. Yuan M, Wen-Xia Z, Jun-Ping C and Yong-Xiang Z. Agerelated changes in the oestrous cycle and reproductive hormones in senescence-accelerated mouse. Reproduction, fertility, and development. 2005; 17:507-512.
32. McAfoose J and Baune BT. Evidence for a cytokine model of cognitive function. Neuroscience and biobehavioral reviews. 2009; 33:355-366.
33. Lee KS, Chung JH, Choi TK, Suh SY, Oh BH and Hong CH. Peripheral cytokines and chemokines in Alzheimer's disease. Dementia and geriatric cognitive disorders. 2009; 28:281-287.
34. Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D and Perry VH. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry. 2003; 74:788-789.
35. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC and Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology. 2005; 64:1371-1377.
36. Verdile G, Laws SM, Henley D, Ames D, Bush AI, Ellis KA, Faux NG, Gupta VB, Li QX, Masters CL, Pike KE, Rowe CC, Szoeke C, et al. Associations between gonadotropins, testosterone and beta amyloid in men at risk of Alzheimer's disease. Molecular psychiatry. 2014; 19:69-75.
37. Butchart J, Birch B, Bassily R, Wolfe L and Holmes C. Male sex hormones and systemic inflammation in Alzheimer disease. Alzheimer disease and associated disorders. 2013; 27:153-156.
38. Oitzl MS, Reichardt HM, Joels M and de Kloet ER. Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98:12790-12795.
39. Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, Zink M, Hortnagl H, Flor H, Henn FA, Schutz G and Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stressinduced depressive reactions. The Journal of neuroscience. 2005; 25:6243-6250.
40. Boyle MP, Brewer JA, Funatsu M, Wozniak DF, Tsien JZ, Izumi Y and Muglia LJ. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102:473-478.
41. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R and Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nature genetics. 1999; 23:99-103.
42. Town T, Vendrame M, Patel A, Poetter D, DelleDonne A, Mori T, Smeed R, Crawford F, Klein T, Tan J and Mullan M. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42). Journal of neuroimmunology. 2002; 132:49-59.
43. Kim HD, Cao Y, Kong FK, Van Kampen KR, Lewis TL, Ma Z, Tang DC and Fukuchi K. Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF. Vaccine. 2005; 23:2977-2986.
44. Kim HD, Jin JJ, Maxwell JA and Fukuchi K. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease. Immunology letters. 2007; 112:30-38.
45. Subramanian S and Divya Shree AN. Enhanced Th2 immunity after DNA prime-protein boost immunization with amyloid beta (1-42) plus CpG oligodeoxynucleotides in aged rats. Neuroscience letters. 2008; 436:219-222.
46. Guo W, Sha S, Jiang T, Xing X and Cao Y. A new DNA vaccine fused with the C3d-p28 induces a Th2 immune response against amyloid-beta. Neural regeneration research. 2013; 8:2581-2590.
47. Huang J, Li Z, Yao X, Li Y, Reng X, Li J, Wang W, Gao J, Wang C, Tankersley CG and Huang K. Altered Th1/Th2 commitment contributes to lung senescence in CXCR3-deficient mice. Exp Gerontol. 2013; 48:717-726.
48. Watson RR, Zibadi S, Vazquez R and Larson D. Nutritional regulation of immunosenescence for heart health. Journal of Nutritional Biochemistry. 2005; 16:85-87.
49. Nair S, Fang M and Sigal LJ. The natural killer cell dysfunction of aged mice is due to the bone marrow stroma and is not restored by IL-15/IL-15Ralpha treatment. Aging cell. 2015; 14:180-190.
50. Tarazona R, Campos C, Pera A, Sanchez-Correa B and Solana R. Flow Cytometry Analysis of NK Cell Phenotype and Function in Aging. Methods in molecular biology (Clifton, NJ). 2015; 1343:9-18.
51. Solerte SB, Cravello L, Ferrari E and Fioravanti M. Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease. Annals of the New York Academy of Sciences. 2000; 917:331-340.
52. Masera RG, Prolo P, Sartori ML, Staurenghi A, Griot G, Ravizza L, Dovio A, Chiappelli F and Angeli A. Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease. Psychoneuroendocrinology. 2002; 27:447-461.
53. Marsh SE, Abud EM, Lakatos A, Karimzadeh A, Yeung ST, Davtyan H, Fote GM, Lau L, Weinger JG, Lane TE, Inlay MA, Poon WW and Blurton-Jones M. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Proceedings of theNational Academy of Sciences of the United States of America. 2016; 113:E1316-1325.
54. Maccioni RB, Rojo LE, Fernandez JA and Kuljis RO. The role of neuroimmunomodulation in Alzheimer's disease. Annals of the New York Academy of Sciences. 2009; 1153:240-246.
55. Bevins RA and Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nature Protocols. 2006; 1:1306-1311.
56. Cheng XR, Yang Y, Zhou WX and Zhang YX. Expression of VGLUTs contributes to degeneration and acquisition of learning and memory. Neurobiology of learning and memory. 2011; 95:361-375.
57. He XL, Zhou WQ, Bi MG and Du GH. Neuroprotective effects of icariin on memory impairment and neurochemical deficits in senescence-accelerated mouse prone 8 (SAMP8) mice. Brain Research. 2010; 1334:73-83.
58. Lou G, Zhang Q, Xiao F, Xiang Q, Su Z, Zhang L, Yang P, Yang Y, Zheng Q and Huang Y. Intranasal administration of TAT-haFGF attenuates disease progression in a mouse model of Alzheimer's disease. Neuroscience. 2012; 223:225-237.
59. Shi YQ, Huang TW, Chen LM, Pan XD, Zhang J, Zhu YG and Chen XC. Ginsenoside Rg1 attenuates amyloidbeta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice. Journal of Alzheimers Disease Jad. 2010; 19:977-989.
60. Vorhees CV and Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature Protocols. 2006; 1:848-858.
61. Miekley B, Traulsen I and Krieter J. Principal component analysis for the early detection of mastitis and lameness in dairy cows. Journal of Dairy Research. 2013; 80:335-343.
62. Cheng XR, Cui XL, Zheng Y, Zhang GR, Li P, Huang H, Zhao YY, Bo XC, Wang SQ and Zhou WX. Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model. Frontiers in Aging Neuroscience. 2013; 5:65-65.
63. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Research. 2003; 13:2498-2504.